Voyager Therapeutics (VYGR) Announces CFO Transition
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Voyager Therapeutics, Inc. (Nasdaq: VYGR) announced a transition process for Jeff Goater, Voyager’s chief financial officer, who has advised the Company of his plans to pursue other career opportunities. As the Company initiates a search for this role, Jeff will remain in his current position until January 2017, after which time he has agreed to serve as a consultant to the Company.
“Jeff has done an extraordinary job since joining our company more than three years ago as one of our first employees and it has been a great pleasure working closely with him,” said Steve Paul, M.D., president and chief executive officer of Voyager. “Jeff played a major role transitioning Voyager from a private to a public company, facilitating the advancement of our clinical and preclinical programs. On behalf of the Board and the rest of our leadership team here at Voyager, we thank him for his service and wish him success in his next endeavor.”
“Voyager truly has been an incredible opportunity and rewarding experience for me and it has been a pleasure to work along side such a talented and dedicated group,” said Mr. Goater. “I look forward to continuing to work with the Company to ensure a seamless and smooth transition of my duties.”
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Clayton Williams Energy (CWEI) Enters Agreement to Sell Giddings Area Assets in $400M Deal; Names New COO
- The New York Times Co. (NYT) Announces Acquisition of Two Product-Recommendation Service Companies
- Vail Resorts (MTN) Names New Board Member
Create E-mail Alert Related CategoriesManagement Changes, Management Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!